Free Trial

Jushi Holdings Inc. (OTCMKTS:JUSHF) Short Interest Down 19.3% in May

Jushi logo with Medical background

Jushi Holdings Inc. (OTCMKTS:JUSHF - Get Free Report) was the recipient of a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 603,500 shares, a decline of 19.3% from the April 30th total of 747,700 shares. Based on an average daily volume of 196,900 shares, the days-to-cover ratio is currently 3.1 days. Currently, 0.4% of the company's shares are sold short.

Jushi Trading Up 1.7%

Shares of JUSHF traded up $0.01 during trading hours on Thursday, reaching $0.30. 29,025 shares of the company traded hands, compared to its average volume of 200,963. The firm has a market cap of $58.01 million, a price-to-earnings ratio of -1.09 and a beta of -0.86. Jushi has a 12-month low of $0.22 and a 12-month high of $0.69. The stock's fifty day moving average price is $0.32 and its 200 day moving average price is $0.32.

Jushi (OTCMKTS:JUSHF - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.03). The firm had revenue of $63.85 million for the quarter, compared to analysts' expectations of $66.23 million. On average, research analysts forecast that Jushi will post -0.23 earnings per share for the current year.

Jushi Company Profile

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

Further Reading

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines